Building on the FDA's roadmap to reduce animal testing in drug development, the National Institutes of Health has awarded $87 million over three years to establish the Standardized Organoid Modeling (SOM) Center. This initiative aims to standardize organoid protocols to enhance reproducibility and foster alternatives to traditional in vivo models. The program supports innovation that could transform preclinical research paradigms, promising more human-relevant and ethically responsible biomedical research.